Advertisement

Topics

Can T-DM1 Match Chemotherapy Plus Dual Blockade in HER2+ Breast Cancer?

20:00 EDT 13 Jun 2019 | Cancer Networks

A phase II trial tested docetaxel, trastuzumab, and pertuzumab vs T-DM1 for the neoadjuvant treatment of HER2+ breast cancer.

Original Article: Can T-DM1 Match Chemotherapy Plus Dual Blockade in HER2+ Breast Cancer?

NEXT ARTICLE

More From BioPortfolio on "Can T-DM1 Match Chemotherapy Plus Dual Blockade in HER2+ Breast Cancer?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...